$4.34
arrow_drop_up6.89%Key Stats | |
---|---|
Open | $4.07 |
Prev. Close | $4.10 |
EPS | -0.34 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $430.86M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 3.99 | 4.25 |
52 Week Range | 2.45 | 5.54 |
Ratios | |
---|---|
EPS | -0.34 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Global Transfection Technologies Market Predicted to Surpass USD 2.33 billion, at a CAGR of 9.0% by 2032 - Report ... - GlobeNewswire
Does MaxCyte (MXCT) Have the Potential to Rally 85% as Wall Street Analysts Expect?
Recent Price Trend in MaxCyte (MXCT) is Your Friend, Here's Why
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates